Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary lymphoma of bone.
Chin HW, McGuire MH, Block M, Frank AR, Boman BM, Mailliard JA. Chin HW, et al. Among authors: mailliard ja. Nebr Med J. 1990 Nov;75(11):303-6. Nebr Med J. 1990. PMID: 2259387
Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung.
Shaw EG, McGinnis WL, Jett JR, Su JQ, Frank AR, Mailliard JA, Engel RE, Wiesenfeld M, Rowland KM Jr. Shaw EG, et al. Among authors: mailliard ja. J Natl Cancer Inst. 1993 Feb 17;85(4):321-3. doi: 10.1093/jnci/85.4.321. J Natl Cancer Inst. 1993. PMID: 8381189 Clinical Trial. No abstract available.
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.
Martenson JA Jr, Hyland G, Moertel CG, Mailliard JA, O'Fallon JR, Collins RT, Morton RF, Tewfik HH, Moore RL, Frank AR, Urias RE, Deming RL. Martenson JA Jr, et al. Among authors: mailliard ja. Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):299-303. doi: 10.1016/0360-3016(96)00016-8. Int J Radiat Oncol Biol Phys. 1996. PMID: 8635937 Clinical Trial.
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R. Jett JR, et al. Among authors: mailliard ja. Cancer. 2003 May 15;97(10):2498-503. doi: 10.1002/cncr.11377. Cancer. 2003. PMID: 12733149 Free article. Clinical Trial.
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.
Schild SE, Stella PJ, Geyer SM, Bonner JA, Marks RS, McGinnis WL, Goetz SP, Kuross SA, Mailliard JA, Kugler JW, Schaefer PL, Jett JR. Schild SE, et al. Among authors: mailliard ja. Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):370-8. doi: 10.1016/s0360-3016(02)02930-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 12243810 Clinical Trial.
143 results